Memphis, TN, United States of America

Wing Leung

This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Miltenyi Biotec B.v. Co., Kg, St. Jude Children's Research Hospital. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wing Leung. Retrieved from https://idiyas.com/inventor/wing-leung-ejf8k2zu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Memphis, TN (US) (2019 - 2022)
  • Boston, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wing Leung

Introduction

Wing Leung is a notable inventor based in Memphis, TN (US), recognized for his significant contributions to the field of biomedical research. With a total of 4 patents, he has made strides in developing innovative methods and technologies that enhance the understanding and treatment of various medical conditions.

Latest Patents

Among his latest patents, Wing Leung has developed a method for NK cell transduction. This invention discloses an in-vitro method for transferring biological material into activated NK cells using a pseudotyped retroviral vector particle or a virus-like particle. The process involves the activation of NK cells followed by the addition of the vector particle, which comprises a modified baboon endogenous retrovirus (BaEV) envelope glycoprotein. This innovation allows for the effective transfer of biological material into activated NK cells, potentially improving therapeutic outcomes.

Another significant patent is the chimeric antigen receptor specific for the BDCA2 antigen. This invention includes a chimeric antigen receptor (CAR) that comprises an antigen binding domain specific for BDCA2. The engineered cells expressing this CAR are designed for the treatment of cancer, particularly targeting cancerous cells that express BDCA2, such as those found in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Career Highlights

Wing Leung has worked with prestigious organizations, including St. Jude Children's Research Hospital and Miltenyi Biotec B.V. Co., KG. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Wing Leung has collaborated with talented individuals, including Rafijul Bari and Markus Granzin. These partnerships have fostered an environment of innovation and have led to the development of impactful technologies in the biomedical sector.

Conclusion

Wing Leung's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…